skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
FOLFIRI-Cetuximab Regimen (Code C104152)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: FOLFIRI-Cetuximab Regimen

Definition: A chemoimmunotherapy regimen consisting of leucovorin (folinic acid), 5-fluorouracil, and irinotecan plus cetuximab used for the treatment of metastatic colorectal cancer that is positive for the expression of the epidermal growth factor receptor (EGFR) and the wild-type form of KRAS.

Label: FOLFIRI-Cetuximab Regimen

NCI Thesaurus Code: C104152 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL439099  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
FOLFIRI-Cetuximab Regimen
FOLFIRI-Erbitux Regimen
Leucovorin-Fluorouracil-Irinotecan-Cetuximab Regimen

External Source Codes: 
PDQ Closed Trial Search ID 744911
PDQ Open Trial Search ID 744911 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C104152
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom